BioNews Services’ Multiple Sclerosis News Today successfully wrapped up its week-long coverage of the Consortium of Multiple Sclerosis Centers’ 2016 conference in National Harbor, Maryland — the largest MS conference in North America. Multiple Sclerosis News Today worked closely with CMSC organizers June Halper and Marguerite Herman as far back as March, helping to publicize the upcoming conference highlights, breakthrough presentations, and other important features that are relevant to Multiple Sclerosis patients. After the close of the CMSC, Ms. Halper and the leadership of the CMSC said that they “deeply appreciated the interest and support shown for our conference by BioNews Services. We appreciate that information from our meeting has been and will be shared by the wider professional community.”
The pre-conference coverage, together with BioNews’ unique approach to comprehensive on-site reporting through the lens of the MS patient, dominated social media and produced a myriad of news features, social media livestreaming reports, and exclusive video interviews that allowed patients, caregivers, and other stakeholders in MS research and disease management who were otherwise unable to attend the event in person.
Most biotech and healthcare conferences — even the most prestigious and influential ones — are rarely covered by the media, and when they are, the coverage is usually either token and/or geared towards industry. The BioNews conference coverage team is the only one of its kind that creates, publishes and distributes a wide range of content from the floor of conferences that are specifically geared toward the patient and caregiver demographic. Because pharma and biotech companies are increasingly focused on making direct contact with patients and caregivers, adding BioNews Services as the official sponsored media partner of a conference adds tremendous value to all attendees. Our coverage amplifies sponsorship efforts at the conference extending well beyond the exhibition floor and presentation rooms.
Throughout the course of the event, Multiple Sclerosis News Today produced the following content:
- 72 published stories, including feature-length articles on breakthrough presentations, novel therapies, new insights into the disease, and compelling human interest stories — all sourced from the CMSC.
- 12 exclusive video interviews, shot from the floor of the CMSC. Interviews include poignant commentary from the world’s preeminent MS researchers, leading influencers in the MS sector, patient advocates, and conference organizers.
- 83 professional photos shot by award-winning photo journalist Eileen Soler, capturing the on-site experience of CMSC for the entire world to see.
- Over 1000 tweets, accompanying dozens of Facebook posts promoting the conference program and CMSC content.
- Livestreaming of presentations via the Multiple Sclerosis News Today Twitter account, giving followers a play-by-play report and analysis of the presentations in real time.
In addition, CMSC 2016 was the first conference where BioNews established an on-site newsroom in the heart of the conference’s exhibition hall. This booth allowed attendees to see Multiple Sclerosis News Today in action first-hand, and offered a central location where interviews could be shot and stories drafted and filed by our editorial team.
The booth also featured a 55-inch high-definition monitor that provided real-time streaming of all of Multiple Sclerosis News Today’s published content across the website, Twitter, Facebook, Pinterest, and YouTube.
This video offers an insightful behind-the scenes view of the conference:
The wide ranging effort by the Multiple Sclerosis News Today team led to two significant benefits to the conference: for conference attendees, the on-site presence created a “buzz” in the atmosphere, knowing that the presentations and interviews were being broadcasted out across the web. For those tuning on via Multiple Sclerosis News Today worldwide, the coverage gave them insights into the current research and development concerning MS that they would have otherwise not had access to.
Here are a few stand-out achievements from the conference:
Two Million Sets of Eyes on Twitter
Twitter has been the go-to social media platform for covering biotech and healthcare conferences in real-time. While most conferences do not allow live broadcasting of presentations, “livestreaming” — also known as “liveblogging” — is generally allowed. Our team uses Twitter to give followers a play-by-play report of presentations, using key quotes and photographs to bring the presentation experience life.
Two million impressions — that was the number of times that #CMSC16-tagged tweets were seen online:
Multiple Sclerosis News Today also completely dominated the number of tweets for the conference — even other popular MS-related online publications such as MS Unites or MultipleSclerosis.net paled in comparison.
12 Video Interviews With the Most Influential MS Researchers and Advocates
It isn’t unusual for those with MS and other chronic diseases to go for up to six months without seeing their specialist. The lack of contact with MS care professionals can sometimes make patients feel hopeless — as if nothing new is being advanced to improve their care and combat the effects and progression of the disease. That, however, is a perception in the patient population that can be altered in part through the on-site, patient-centric conference coverage that BioNews offers.
Our exclusive video interviews touched base with some of the most talented researchers and advocates, including Dr. Peter Chin of Genentech, who talked at length about the prospect of experimental therapy Ocrelizumab in treating PPMS; Rosalind Kalb of the MS Society, who spoke about the biggest challenges today in MS care and treatment; Klaus Martin of Bayer, who spoke at length about the novel technologies that the company is working on, including innovative, new drug delivery systems; and Dr. Munschauer of EMD Serono, who talked at length about the viability of Rebif.
You can watch all of the videos here:
CMSC By the Numbers
When BioNews covers wall-to-wall coverage of an event, the numbers of users that we drive to our disease-specific websites are impressive. Online patient populations are constantly in search of news regarding the latest science and research breakthroughs. As a result, coverage of these events offers them a burst of new hope and insight.
Traffic for the Multiple Sclerosis News Today website was up an impressive 34% compared to the previous period:
Facebook also played a key role in the success of getting the word out about CMSC and keep users tuned in throughout the conference. Over the course of the past 28 days, the MS News Today Facebook page reached over 120,000 people, with over 9,000 video views in the past week from the time of this article being published.
A New Dimension to Conferences
Biotech and healthcare conferences need not be limited to the research and drug development communities any longer. The presentations and discoveries at conferences such as the CMSC are valuable to the millions of patients and caregivers out there who cannot attend the conference, but who are interested in what’s new in research and development. BioNews offers conferences the opportunity to create a new, value-added promotional channel for sponsors and stakeholders, opening up their conference to the world.
Click here to learn more about BioNews’ conference news services.
- The MS Alphabet: Hemiparesis, Helper T-cells, HLA and Other ‘H’ Terms September 15, 2017
- Choosing Happiness September 14, 2017
- Phaware Podcast: Peter Leary, MD, Part 2 September 14, 2017
- Jazz Partners with ImmunoGen to Develop Antibody-Drug Conjugate for AML, Other Blood Diseases September 14, 2017
- Uptravi Delays Progression of PAH Associated with Lupus and Other Connective Tissue Diseases, Trial Shows September 14, 2017
- Rocapuldencel-T Improves Survival in Renal Cell Carcinoma Patients, Phase 3 Trial Suggests September 14, 2017
- Immuno-oncology Becoming Established as Fifth Pillar of Cancer Therapy, Analysts Say September 14, 2017
- Favorable Interim Data Presented for Tyme’s SM-88 Phase 2 Trial for Prostate Cancer Patients September 14, 2017
- Care for Cardiac Problems in Mitochondrial Disorders Advancing, But More Needed, Scientist Argues September 14, 2017
- National Institutes of Health Awards $30 Million to Support Development of 3-D Models of Disease September 14, 2017